|
What's New at the New View Campaign
Date |
Title |
|
5/1/2015 |
UPCOMING FDA FLIBANSERIN ADVISORY COMMITTEE HEARING June 4, 2015 |
|
SPROUT Pharma is submitting flibanserin for the 3rd time to the FDA and has requested a public hearing. The FDA has called a hearing of BOTH the repro/urol/bone health committee (the usual drug approver for sex drugs) AND and the drug safety/risk assessment committee (big guns in terms of safety issues). Here's the general announcement for the meeting and you can find all the advisory committee participants thru searching the FDA website. The New View will attend and speak on issues of marketing, safety, and efficacy during the Public Speaker section. |
back to all news items
|
|